The Nephrocare Health IPO is one of the most anticipated offerings in the health IPO category, especially with the company being among the fastest-growing dialysis clinics operators in India.
Backed by strong investors like Bessemer Venture Partners Trust, Investcorp Growth Opportunity Fund, and Edoras Investment Holdings Pte, Nephrocare Health Services Ltd has built a reputation for clinical excellence, operational efficiency, and patient-centric care across Tier II and Tier III cities.
With a growing network of clinics across states and 4 union territories and expansion into international markets such as Philippines, Uzbekistan, and Nepal, the company is aiming for sustained, technology-led growth in Asian healthcare.
This blog covers the Nephrocare Health IPO details, IPO date, IPO price band, financial performance, IPO allotment, and how retail investors can apply.
Nephrocare Health IPO Details
| Detail | Information |
|---|---|
| IPO Date | December 10, 2025 to December 12, 2025 |
| Face Value | ₹2 per share |
| Health IPO Price Band | ₹438 to ₹460 per share |
| Lot Size | 32 Shares |
| Total Issue Size | 1,89,35,819 shares (₹871.05 Cr) |
| Fresh Issue | 76,82,717 shares (₹353.40 Cr) |
| Offer for Sale | 1,12,53,102 shares (₹517.64 Cr) |
| Employee Discount | ₹41 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Pre-Issue Shares | 9,26,50,799 |
| Post-Issue Shares | 10,03,33,516 |
The Nephrocare Health IPO consists of a mix of fresh capital and OFS, aimed at scaling clinic operations, setting up new dialysis clinics, and scheduled repayment of borrowings availed.
Nephrocare Health IPO Timeline (IPO Date & Important Events)
| Event | Date |
|---|---|
| Nephrocare Health IPO Opens | Wed, Dec 10, 2025 |
| IPO Close Date | Fri, Dec 12, 2025 |
| IPO Allotment | Mon, Dec 15, 2025 |
| Initiation of Refunds | Tue, Dec 16, 2025 |
| Credit of Shares to Demat | Tue, Dec 16, 2025 |
| IPO Listing Date | Wed, Dec 17, 2025 |
| UPI Mandate Cut-off | 5 PM on Dec 12 |
Company Overview – Nephrocare Health Services Ltd
Nephrocare Health Services Ltd is one of India’s largest and fastest-growing dialysis providers, operating a network of high-quality dialysis clinics, mobile dialysis units, wellness programs, and in-house pharmacies across 20+ states and multiple union territories.
The company is considered one of Asia’s emerging leaders in:
Sustainable dialysis leadership
Advanced technology, medical automation & organic growth
Internationally patient-centric leadership
Cost efficiencies and operational excellence
They have strong relationships with major hospitals including:
Care Hospitals
Ruby Hall Clinic
Jehangir Hospital
Fortis Escorts
Future plans include expanding to Philippines, Uzbekistan, Nepal, aligning with their vision to become Asia’s largest dialysis chain.
Business Overview – Dialysis Clinics & Healthcare Expansion
Dialysis Clinics
Nephrocare operates:
Standalone dialysis centers
Clinics inside partner hospitals
Mobile dialysis units for underserved areas
Clinics in Tier II and Tier III cities
The company focuses on reducing dependency on the world’s largest dialysis clinic chains and building a strong India-centric network.
International Markets
Nephrocare aims to scale into international markets with:
Regulatory compliance
Strong governance measures
Proven track record in multi-location operations
Capital Expenditure & Net Proceeds
The net proceeds will be used for:
Expanding new dialysis clinics
Setting up technology-enabled centers
Upgrading the software units layout
Scheduled repayment of borrowings
General corporate purposes
Anchor Investors & Private Equity Backing
Strong early interest has been seen from:
Investcorp Growth Opportunity Fund
Bessemer Venture Partners Trust
Edoras Investment Holdings Pte
Leading healthcare parent companies globally
This boosts confidence among retail investors and qualified institutional buyers.
Financial Information – Nephrocare Health Services Ltd
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 1,193.68 | 996.46 | 806.02 | 666.23 |
| Total Income | 483.97 | 769.92 | 574.72 | 443.26 |
| Profit After Tax | 14.23 | 67.10 | 35.13 | -11.79 |
| EBITDA | 110.31 | 166.64 | 99.66 | 48.60 |
| Net Worth | 716.06 | 594.21 | 423.55 | 384.73 |
| Reserves & Surplus | 704.14 | 578.68 | 408.57 | 383.50 |
| Total Borrowing | 207.04 | 225.80 | 243.37 | 196.21 |
Amount in ₹ Crore
Key Takeaways
Revenue increased 34% YoY
PAT surged 91%, showing strong operational improvement
Steady increase in assets due to clinic expansion
Debt levels improving with scheduled repayment plans
IPO Allotment – How to Check Nephrocare Health IPO Allotment Status
You can check Nephrocare Health IPO allotment via:
KFin Technologies Ltd (Registrar)
Visit the official KFinTech allotment link and select Nephrocare Health IPO from the dropdown.
BSE IPO Allotment Page
Select issue name → Enter PAN or application number.
Your Broker App
Many apps show allotment under "IPO applications".
Keywords covered:
IPO allotment, Nephrocare Health IPO allotment, allotment status, IPO allotment status, check Nephrocare Health.
IPO Listing – IPO Listing Date & Market Expectations
IPO Listing Date: December 17, 2025
Shares will list on both BSE and NSE.
Listing may attract attention from both domestic and international investors due to:
Strong sector (kidney care & dialysis)
Backing from global investors
Expanding international presence
How Retail Investors Can Apply (Demat + UPI)
To apply for the Nephrocare Health IPO, investors need:
Active demat account
UPI ID
Minimum order quantity of 32 shares
Steps:
Open your broker app (Zerodha, Groww, AngelOne, etc.)
Search Nephrocare Health IPO
Enter bid – floor price, cap price, or custom price
Approve UPI mandate
Wait for allotment & listing
Conclusion
The Nephrocare Health IPO stands out in the health IPO category thanks to its strong presence in the dialysis segment, proven track record, cost-efficient operating model, and expansion into international markets.
Its financial performance, scalable business model, and international collaborations make it compelling for long-term investors looking at the healthcare space.
However, investors should also evaluate regulatory risks, competitive intensity, and global expansion timelines before applying.
Apply for your next IPO seamlessly on CubePlus by Tradejini : https://cubeplus.tradejini.com/app/orders/ipo
Disclaimer: The information provided in our blogs is for informational purposes only and should not be construed as financial, investment, or trading advice. Trading and investing in the securities market carries risk. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Copyrighted and original content for your trading and investing needs.
© 2025 — Tradejini. All Rights Reserved.
